"10.1371_journal.pone.0051314","plos one","2012-12-11T00:00:00Z","Ann L McEvoy; Hiofan Hoi; Mark Bates; Evgenia Platonova; Paula J Cranfill; Michelle A Baird; Michael W Davidson; Helge Ewers; Jan Liphardt; Robert E Campbell","Biophysics Graduate Group, University of California, Berkeley, California, United States of America; Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada; Department of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; Institute of Biochemistry, Eidgenössische Technische Hochschule (ETH) Zurich, Zurich, Switzerland; National High Magnetic Field Laboratory and Department of Biological Science, The Florida State University, Tallahassee, Florida, United States of America; California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, California, United States of America; Bay Area Physical Sciences – Oncology Center, University of California, Berkeley, California, United States of America; Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America; Department of Physics, University of California, Berkeley, California, United States of America","¶a Correspondence related to super-resolution imaging techniques should be addressed to ALM.","New pcFPs that originate from the Campbell lab and are described in this manuscript are covered by US patent application 12/960,397, which is titled Photoconvertible fluorescent proteins and is jointly owned by the University of Alberta and Allele Biotechnology. Allele Biotechnology is also the licensed distributor of plasmids containing genes encoding these pcFPs. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Ann L McEvoy","ALME",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
